The global surgical stapling device market is forecasted to experience steady growth, reaching a valuation of US$ 5,930.6 million by 2033, up from US$ 3,977.4 million in 2023, at a CAGR of 4.1% during the forecast period.
Surgical stapling devices are increasingly favored in operating rooms due to their efficiency, precision, and ability to reduce surgical time. These devices provide an effective alternative to sutures, particularly in complex surgeries, minimizing the risk of infections and enhancing post-operative recovery outcomes.
Rising Surgical Procedures: An increasing number of surgeries, including bariatric, thoracic, and gastrointestinal procedures, is boosting the demand for surgical staplers.
Technological Advancements: Innovations such as powered surgical staplers and disposable models are gaining traction for their convenience and improved safety features.
Minimally Invasive Surgeries: The growing popularity of minimally invasive techniques is fueling the adoption of surgical stapling devices for precise and efficient tissue closure.
Global Healthcare Expansion: Investments in healthcare infrastructure, particularly in emerging economies, are further driving market growth.
Market Outlook:
The surgical stapling device market is poised for steady expansion as healthcare providers continue to prioritize efficiency and patient safety during surgical procedures. The increasing preference for advanced stapling technologies is expected to further solidify the market’s position globally.
Growth Drivers
Increasing Surgical Procedures: The rising number of surgical interventions, including minimally invasive surgeries, is driving demand for efficient and reliable surgical stapling devices.
Technological Advancements: Innovations in stapling technology, including powered and disposable staplers, are enhancing surgical outcomes and efficiency, contributing to market growth.
Preference for Minimally Invasive Techniques: As healthcare providers increasingly adopt minimally invasive surgical techniques, the demand for advanced stapling devices that facilitate quicker and safer procedures is on the rise.
Patient Safety and Efficiency: Surgical staplers offer advantages such as reduced operating time and improved wound closure reliability compared to traditional suturing methods, making them a preferred choice in many surgical settings.
Market Trends
The market is witnessing a shift towards disposable surgical stapling devices, which are favored for their convenience and reduced risk of infection.
There is an increasing focus on developing smart stapling technologies that provide real-time feedback during surgeries to improve accuracy and outcomes.
Regional Insights
North America is expected to dominate the market due to advanced healthcare infrastructure and high adoption rates of innovative surgical technologies.
The Asia-Pacific region is projected to be the fastest-growing market, driven by increasing healthcare investments and a rising number of surgical procedures.
Competitive Landscape
Companies operating in the surgical stapling devices market are competitive by nature, with a few global and local competitors.
Key players in the global surgical stapling devices market are focusing on tapping emerging markets to increase market share and the consumer base through exclusive product launches and approval in the emerging market. Some of the recent instances include
In October 2021, Medtronic plc announced that it had received CE (Conformité Européenne) Mark for the Hugo™ robotic-assisted surgery (RAS) system, authorizing the sale of the system in Europe. CE Mark approval is for urologic and gynecologic procedures, which make up about half of all robotic procedures performed today.
In October 2020, 3M announced the availability of PREVENA RESTOR AXIO•FORM™ Incision Management System, designed to manage post-operative incisions and the surrounding soft tissue envelope following the orthopedic surgical repair of lower extremity fractures.
Key Companies Profiled
Medtronic plc.
Johnson & Johnson Services, Inc.
3M Company
Dextera Surgical Inc.
Purple Surgical Holdings Limited
Meril Life Sciences Pvt. Ltd.
Grena Ltd.
Surgical Stapling Devices Market Segmentation
By Product:
Powered Surgical Stapling Device
Manual Surgical Stapling Device
By Usage:
Disposable Surgical Stapling Device
Reusable Surgical Stapling Device
By Stapling Type:
Straight
Curved
Circular
By Indication:
Skin
Digestive Tract
Blood Vessels
Hernia
Lung
Others
By Region:
North America
Latin America
Western Europe
Eastern Europe
South Asia and Pacific
East Asia
Middle East and Africa
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA T: +1-347-918-3531